CLINICAL_TRIALS
trial_result
· 2020-11-03
Clinical Trial Update: Comparison of BTD and BCD Based Regimens in the Treatment of AL Amyloidosis [Phase 4]
Summary
A Phase 4 trial comparing BTD and BCD regimens for Immunoglobulin Light-Chain Amyloidosis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Guangdong Provincial People's Hospital | Conditions: Immunoglobulin Light-Chain Amyloidosis | Phase 4 | Status: UNKNOWN